Sep 22 | Mar 22 | Sep 21 | Mar 21 | Sep 20 | |
---|---|---|---|---|---|
Income Statement | - | ||||
Total Revenue | - | - | - | - | - |
Gross Profit | - | - | - | - | - |
EBIT | - | - | - | - | - |
EBITDA | - | - | - | - | - |
Net Income Common Stockholders | - | - | - | - | - |
Balance Sheet | - | ||||
Cash, Cash Equivalents and Short-Term Investments | $ 15.70M | $ 10.50M | $ 11.50M | $ 19.90M | $ 19.60M |
Total Assets | $ 258.70M | $ 195.10M | $ 205.40M | $ 194.80M | $ 211.50M |
Total Debt | $ 70.60M | $ 35.80M | $ 40.40M | $ 53.20M | $ 62.20M |
Net Debt | $ 54.90M | $ 25.30M | $ 28.90M | $ 33.30M | $ 42.60M |
Total Liabilities | $ 221.70M | $ 189.30M | $ 202.10M | $ 200.90M | $ 223.00M |
Stockholders Equity | $ 37.00M | $ 5.80M | $ 3.30M | $ -6.10M | $ -11.50M |
Cash Flow | - | ||||
Free Cash Flow | - | - | - | - | - |
Operating Cash Flow | - | - | - | - | - |
Investing Cash Flow | - | - | - | - | - |
Financing Cash Flow | - | - | - | - | - |